Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 191

1.

Diagnostic accuracy of 18F-FDG PET/CT for detecting recurrence in patients with primary skeletal Ewing sarcoma.

Sharma P, Khangembam BC, Suman KC, Singh H, Rastogi S, Khan SA, Bakhshi S, Thulkar S, Bal C, Malhotra A, Kumar R.

Eur J Nucl Med Mol Imaging. 2013 Jul;40(7):1036-43. doi: 10.1007/s00259-013-2388-9. Epub 2013 Apr 5.

PMID:
23558689
[PubMed - indexed for MEDLINE]
2.

Role of FDG PET-CT in detecting recurrence in patients with uterine sarcoma: comparison with conventional imaging.

Sharma P, Kumar R, Singh H, Jeph S, Sharma JB, Jain SK, Sharma DN, Bal C, Malhotra A.

Nucl Med Commun. 2012 Feb;33(2):185-90. doi: 10.1097/MNM.0b013e32834e41a6.

PMID:
22107993
[PubMed - indexed for MEDLINE]
3.

18F-FDG PET-CT for detecting recurrent gastric adenocarcinoma: results from a Non-Oriental Asian population.

Sharma P, Singh H, Suman SK, Sharma A, Reddy RM, Thulkar S, Bal C, Malhotra A, Kumar R.

Nucl Med Commun. 2012 Sep;33(9):960-6. doi: 10.1097/MNM.0b013e328355b694.

PMID:
22692579
[PubMed - indexed for MEDLINE]
4.

Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.

Kanzaki R, Higashiyama M, Maeda J, Okami J, Hosoki T, Hasegawa Y, Takami M, Kodama K.

Interact Cardiovasc Thorac Surg. 2010 Jun;10(6):1009-14. doi: 10.1510/icvts.2009.227538. Epub 2010 Mar 2.

PMID:
20197344
[PubMed - indexed for MEDLINE]
Free Article
5.

Differentiation between malignant and benign pathologic fractures with F-18-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography.

Shin DS, Shon OJ, Byun SJ, Choi JH, Chun KA, Cho IH.

Skeletal Radiol. 2008 May;37(5):415-21. doi: 10.1007/s00256-008-0462-3. Epub 2008 Feb 29.

PMID:
18309481
[PubMed - indexed for MEDLINE]
6.

(18) F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of recurrent bone and soft tissue sarcoma.

Al-Ibraheem A, Buck AK, Benz MR, Rudert M, Beer AJ, Mansour A, Pomykala KL, Haller B, Juenger H, Scheidhauer K, Schwaiger M, Herrmann K.

Cancer. 2013 Mar 15;119(6):1227-34. doi: 10.1002/cncr.27866. Epub 2012 Dec 11.

PMID:
23233156
[PubMed - indexed for MEDLINE]
Free Article
7.

Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma.

Ho CL, Chen S, Yeung DW, Cheng TK.

J Nucl Med. 2007 Jun;48(6):902-9. Epub 2007 May 15.

PMID:
17504862
[PubMed - indexed for MEDLINE]
Free Article
8.

Diagnostic value of 18F-FDG PET/CT in comparison to bone scintigraphy, CT and 18F-FDG PET for the detection of bone metastasis.

Liu NB, Zhu L, Li MH, Sun XR, Hu M, Huo ZW, Xu WG, Yu JM.

Asian Pac J Cancer Prev. 2013;14(6):3647-52.

PMID:
23886160
[PubMed - indexed for MEDLINE]
Free Article
9.

Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer.

Qiu ZL, Xue YL, Song HJ, Luo QY.

Nucl Med Commun. 2012 Dec;33(12):1232-42. doi: 10.1097/MNM.0b013e328358d9c0.

PMID:
23111353
[PubMed - indexed for MEDLINE]
10.

Diagnostic accuracy of virtual 18F-FDG PET/CT bronchoscopy for the detection of lymph node metastases in non-small cell lung cancer patients.

Herbrik M, Treffert J, Geiger B, Riegger C, Hartung V, Rosenbaum-Krumme SJ, Forsting M, Antoch G, Heusner TA.

J Nucl Med. 2011 Oct;52(10):1520-5. doi: 10.2967/jnumed.111.092593. Epub 2011 Sep 9.

PMID:
21908390
[PubMed - indexed for MEDLINE]
Free Article
11.

The utility of FDG-PET/CT as an effective tool for detecting recurrent colorectal cancer regardless of serum CEA levels.

Sanli Y, Kuyumcu S, Ozkan ZG, Kilic L, Balik E, Turkmen C, Has D, Isik G, Asoglu O, Kapran Y, Adalet I.

Ann Nucl Med. 2012 Aug;26(7):551-8. doi: 10.1007/s12149-012-0609-0. Epub 2012 May 30.

PMID:
22644560
[PubMed - indexed for MEDLINE]
12.

Is methylene diphosphonate bone scan necessary for initial staging of Ewing sarcoma if 18F-FDG PET/CT is performed?

Ulaner GA, Magnan H, Healey JH, Weber WA, Meyers PA.

AJR Am J Roentgenol. 2014 Apr;202(4):859-67. doi: 10.2214/AJR.13.11239.

PMID:
24660717
[PubMed - indexed for MEDLINE]
13.

F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging.

Gallowitsch HJ, Kresnik E, Gasser J, Kumnig G, Igerc I, Mikosch P, Lind P.

Invest Radiol. 2003 May;38(5):250-6.

PMID:
12750613
[PubMed - indexed for MEDLINE]
14.

Impact of FDG PET for staging of Ewing sarcomas and primitive neuroectodermal tumours.

Györke T, Zajic T, Lange A, Schäfer O, Moser E, Makó E, Brink I.

Nucl Med Commun. 2006 Jan;27(1):17-24.

PMID:
16340719
[PubMed - indexed for MEDLINE]
15.

Positron emission tomography/computed tomography with 18fluoro-deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcoma.

Arush MW, Israel O, Postovsky S, Militianu D, Meller I, Zaidman I, Sapir AE, Bar-Shalom R.

Pediatr Blood Cancer. 2007 Dec;49(7):901-5.

PMID:
17252575
[PubMed - indexed for MEDLINE]
16.

Primary gastric lymphoma: utility of 18F-fluorodeoxyglucose positron emission tomography-computed tomography for detecting relapse after treatment.

Sharma P, Suman SK, Singh H, Sharma A, Bal C, Malhotra A, Kumar R.

Leuk Lymphoma. 2013 May;54(5):951-8. doi: 10.3109/10428194.2012.717694. Epub 2012 Nov 15.

PMID:
23043310
[PubMed - indexed for MEDLINE]
17.

Impact of ¹⁸F-FDG PET/CT for detecting recurrence of medullary thyroid carcinoma.

Ozkan E, Soydal C, Kucuk ON, Ibis E, Erbay G.

Nucl Med Commun. 2011 Dec;32(12):1162-8. doi: 10.1097/MNM.0b013e32834bbe09.

PMID:
21946617
[PubMed - indexed for MEDLINE]
18.

The Role of 18F-FDG PET/CT in the evaluation of Ascites of Undetermined Origin.

Zhang M, Jiang X, Zhang M, Xu H, Zhai G, Li B.

J Nucl Med. 2009 Apr;50(4):506-12. doi: 10.2967/jnumed.108.056382. Epub 2009 Mar 16.

PMID:
19289438
[PubMed - indexed for MEDLINE]
Free Article
19.

Combined [18F]Fluorodeoxyglucose positron emission tomography and computed tomography (FDG-PET/CT) for detection of recurrent, 131I-negative thyroid cancer.

Finkelstein SE, Grigsby PW, Siegel BA, Dehdashti F, Moley JF, Hall BL.

Ann Surg Oncol. 2008 Jan;15(1):286-92. Epub 2007 Sep 20.

PMID:
17882493
[PubMed - indexed for MEDLINE]
20.

The role of 18F-FDG PET/CT in the metabolic characterization of lung nodules in pediatric patients with bone sarcoma.

Cistaro A, Lopci E, Gastaldo L, Fania P, Brach Del Prever A, Fagioli F.

Pediatr Blood Cancer. 2012 Dec 15;59(7):1206-10. doi: 10.1002/pbc.24242. Epub 2012 Jun 28.

PMID:
22745027
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk